Core Scientific, Inc./tx - 8-K Filing
Core Scientific reports Q3 2026 net income of $1.18B driven by non-cash warrant fair value gains and a 57% Adjusted EBITDA margin. (Items: 2.02 Results of Operations and Financial ConditionOn November 5, 2026, the Company issued a press release announcing its financial results for the, 7.01 Regulation FD DisclosureThe information contained in Item 2, 9.01 Financial Statement and Exhibits(d) Exhibits:ExhibitNo)
Tickers: $CORZ
Read the full article at SEC EDGAR
Part of the story JOHNSON & JOHNSON - 8-K Filing (37 articles)